Master – shall I write your article? Pushing the genie back into the bottle L. Offerhaus EDITORIAL Pages: 779 - 780
Methodological and political issues in clinical pharmacology research by the year 2000 X. CarnéJ. -A. Arnaiz SPECIAL ARTICLE Pages: 781 - 785
Probucol reduces lysophosphatidylcholines in low-density lipoprotein M. YoshinariA. -H. ShiM. Fujishima CLINICAL TRIALS Pages: 787 - 792
Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects S. SundbergL. Lehtonen CLINICAL TRIALS Pages: 793 - 799
The efficacy of buffered ketoprofen in postoperative pain after third molar surgery R. A. SeymourH. WatkinsonU. Moore CLINICAL TRIALS Pages: 801 - 806
Structure–effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination H. R. HaB. StiegerF. Follath PHARMACODYNAMICS Pages: 807 - 814
Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease I. AlafuzoffS. HelisalmiK. Koivisto PHARMACODYNAMICS Pages: 815 - 819
CYP2C19 polymorphism effect on phenobarbitone K. MamiyaA. HadamaS. Higuchi PHARMACOKINETICS AND DISPOSITION Pages: 821 - 825
Simultaneous modelling of flosequinan and its metabolite J. K. LindseyJ. WangI. D. Hind PHARMACOKINETICS AND DISPOSITION Pages: 827 - 836
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers B. JansenU. GraselliM. Müller PHARMACOKINETICS AND DISPOSITION Pages: 837 - 841
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions M. KatohM. NakajimaT. Yokoi PHARMACOKINETICS AND DISPOSITION Pages: 843 - 852
Human halothane metabolism, lipid peroxidation, and cytochromes P 4502A6 and P 4503A4 E. D. KharaschD. C. HankinsK. Cox PHARMACOKINETICS AND DISPOSITION Pages: 853 - 859
Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity M. OhnoI. YamaguchiJ. Azuma PHARMACOKINETICS AND DISPOSITION Pages: 861 - 865
Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke J. F. HokeA. G. DykerK. R. Lees PHARMACOKINETICS AND DISPOSITION Pages: 867 - 872
The impact of problem-based pharmacotherapy training on the competence of rational prescribing of Yemen undergraduate students N. A. G. M. HassanA. A. AbdullaT. P. G. M. de Vries PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 873 - 876
Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences? E. HaffenP. VandelP. R. Bechtel LETTER TO THE EDITORS Pages: 877 - 879
How did such a bad report get published in the EJCP? A. Herxheimer LETTER TO THE EDITORS Pages: 881 - 881
Co-ordinating editor's comments on the letter to the editors by A. Herxheimer Rune Dahlqvist COMMENTS Pages: 883 - 884